Back to AVBP
FMR LLC AVBP Position History
ArriVent BioPharma, Inc. • Healthcare
Quarters held
20
Latest value
$6.3M
Q3 2026
Peak value
$80.9M
First seen
Q1 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2024 | $34.8M |
| Q2 2024 | $36.2M |
| Q3 2024 | $49.8M |
| Q4 2024 | $56M |
| Q1 2025 | $38.4M |
| Q3 2025 | $54.7M |
| Q3 2025 | $8.2M |
| Q4 2025 | $65.5M |
| Q4 2025 | $9M |
| Q4 2025 | $5K |
| Q1 2026 | $59.2M |
| Q1 2026 | $10.3M |
| Q1 2026 | $6K |
| Q2 2026 | $80.9M |
| Q2 2026 | $15.6M |
| Q2 2026 | $12K |
| Q3 2026 | $70M |
| Q3 2026 | $13.6M |
| Q3 2026 | $9K |
| Q3 2026 | $6.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $6.3M | 207.4K | — | — |
| Q3 2026 | $9K | 287 | — | — |
| Q3 2026 | $13.6M | 448.9K | — | — |
| Q3 2026 | $70M | 2.31M | — | — |
| Q2 2026 | $12K | 333 | — | — |
| Q2 2026 | $15.6M | 448.9K | — | — |
| Q2 2026 | $80.9M | 2.33M | — | — |
| Q1 2026 | $6K | 271 | — | — |
| Q1 2026 | $10.3M | 448.3K | — | — |
| Q1 2026 | $59.2M | 2.57M | — | — |
| Q4 2025 | $5K | 254 | — | — |
| Q4 2025 | $9M | 446.6K | — | — |
| Q4 2025 | $65.5M | 3.26M | — | — |
| Q3 2025 | $8.2M | 443.3K | — | — |
| Q3 2025 | $54.7M | 2.96M | — | — |
| Q1 2025 | $38.4M | 2.08M | — | — |
| Q4 2024 | $56M | 2.10M | — | — |
| Q3 2024 | $49.8M | 2.12M | — | — |
| Q2 2024 | $36.2M | 1.95M | — | — |
| Q1 2024 | $34.8M | 1.95M | — | — |
Other funds holding AVBP
$156.9M
$149.1M
$136.5M
$119M
$105.2M
$101.5M